Filing Details

Accession Number:
0001387131-19-002339
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-01 08:22:29
Reporting Period:
2019-03-29
Accepted Time:
2019-04-01 08:22:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP Pharmaceutical Preparations (2834) 261434750
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1563420 Seth Lederman C/O Tonix Pharmaceuticals Holding Corp
509 Madison Ave., Suite 1608
New York NY 10022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2019-03-29 5,000 $2.49 32,670 No 4 P Indirect By 401(k) Plan
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By 401(k) Plan
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 1,767 Direct
Common Stock, $0.001 Par Value 4,590 Indirect By IRA Account
Common Stock, $0.001 Par Value 310 Indirect By spouse
Common Stock, $0.001 Par Value 292 Indirect By Leder Laboratories, Inc.
Common Stock, $0.001 Par Value 292 Indirect By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 Par Value 2,047 Indirect By Lederman & Co., LLC
Common Stock, $0.001 Par Value 325 Indirect By L&L Technologies, LLC
Common Stock, $0.001 Par Value 590 Indirect By Targent Pharmaceuticals, LLC
Footnotes
  1. Reporting person may be deemed to be a control person of this entity.